Rj. Trauger et al., AUTOPROLIFERATION IN HIV-1-INFECTED PATIENTS UNDERGOING ACTIVE HIV-1-SPECIFIC IMMUNOTHERAPY, Clinical and experimental immunology, 100(1), 1995, pp. 7-12
We have observed a treatment-associated autoproliferative response in
cultured peripheral blood mononuclear cells (PBMC) of asymptomatic HIV
-1-infected subjects receiving a gp120-depleted, inactivated HIV-1 ant
igen in incomplete Freund's adjuvant (IFA; HIV-1 Immunogen). The frequ
ency and magnitude of the autoproliferative response appeared to be do
se-related (P < 0.05), and was not observed in subjects receiving IFA
alone. Immunophenotyping of the proliferating cells demonstrated the p
resence of both CD4(+) and CD8(+) lymphocytes, with the CD4(+) blasts
almost exclusively expressing the CD45RO(+) phenotype. A comparison of
this response with the HIV-1-specific antigen stimulation responses i
n this cohort revealed a significant correlation between increases in
HIV-1-specific cell-mediated immunity and autoproliferation (r(2) = 0.
61, P < 0.001). These findings suggest that immunization with the HIV-
1 Immunogen induces an autoproliferative response that may reflect cha
nges in HIV-1-specific cell-mediated immunity in infected individuals.